Series A round brings $33mm to smoking cessation company Chrono Therapeutics
Canaan Partners and 5AM Ventures led a $33mm Series A financing for transdermal drug/device company Chrono Therapeutics Inc. Fountain Healthcare Partners, Mayo Clinic, GE Ventures, and 26 undisclosed investors participated. Executives from Canaan Partners, 5AM Ventures, and Fountain joined Chrono’s board.
- Medical Devices
- Controlled Release
- Drug Delivery
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com